Expertise in
17
conditions

Dr. Wenqing Zhang

Internal Medicine
521 N Lecanto Hwy, 
Lecanto, FL 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
521 N Lecanto Hwy, 
Lecanto, FL 

Overview

Wenqing Zhang is a primary care provider, practicing in Internal Medicine in Lecanto, Florida.

Dr. Zhang is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Ehrlichiosis, Human Monocytic Ehrlichiosis, Lung Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Dr. Zhang is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 7 clinical trials. Dr. Zhang is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Louisville School of Medicine , Internal Medicine

Hospital Affiliations

HCA Florida Oak Hill Hospital
Hca Florida Citrus Hospital
Tampa General Hospital Crystal River

Languages Spoken

English
Mandarin

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Florida Cancer Specialists Pl
521 N Lecanto Hwy, Lecanto, FL 34461

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2026
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug, Biological
Study Drugs: Margetuximab, Trastuzumab, Capecitabine, Eribulin, Gemcitabine, Vinorelbine
Study Phase: Phase 3
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)
Enrollment Status: Completed
Publish Date: June 01, 2023
Intervention Type: Biological, Drug, Other
View 6 Less Clinical Trials

11 Total Publications

Development of mRNA-lipid nanoparticle intrabodies against rickettsial infection.
Development of mRNA-lipid nanoparticle intrabodies against rickettsial infection.
Journal: Journal of biomedical science
Published: April 14, 2025
Similar Doctors
Expertise in
36
conditions
Dr. Dinesh Khanna
Internal Medicine
Expertise in
36
conditions
Dr. Dinesh Khanna
Internal Medicine
Before you request

Premier Medical Associates

1580 Santa Barbara Blvd Ste C, 
The Villages, FL 
 (35.9 miles away)
352-259-2159
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients

Dinesh Khanna is a primary care provider, practicing in Internal Medicine in The Villages, Florida. Dr. Khanna is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Lung Transplant. Dr. Khanna is board certified in American Board Of Internal Medicine. Dr. Khanna is currently accepting new patients.

Expertise in
24
conditions
Dr. Frederick L. Locke
Internal Medicine
Expertise in
24
conditions
Dr. Frederick L. Locke
Internal Medicine

Moffitt Cancer Center, Magnolia Campus

12902 Usf Magnolia Dr, 
Tampa, FL 
 (55.8 miles away)
813-692-4252
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Frederick Locke is a primary care provider, practicing in Internal Medicine in Tampa, Florida. Dr. Locke is highly rated in 24 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Graft, and Bone Marrow Aspiration. Dr. Locke is currently accepting new patients.

Expertise in
49
conditions
Dr. Meena R. Nathan
Internal Medicine
Expertise in
49
conditions
Dr. Meena R. Nathan
Internal Medicine

Meena Nathan Medical Clinic

840 S Bea Ave, 
Inverness, FL 
 (6.7 miles away)
352-637-6300
Languages Spoken:
English
See accepted insurances

Meena Nathan is a primary care provider, practicing in Internal Medicine in Inverness, Florida. Dr. Nathan is highly rated in 49 conditions, according to our data. Her clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, Endoscopy, and Pacemaker Implantation.

Frequently Asked Questions about Dr. Wenqing Zhang

How do I make an appointment with Dr. Wenqing Zhang?

You can book an appointment with Dr. Wenqing Zhang by calling their office at 352-746-0707. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Wenqing Zhang a top-rated expert for Ehrlichiosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Wenqing Zhang is classified as an Advanced expert for Ehrlichiosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Wenqing Zhang specialize in?

While Dr. Wenqing Zhang is a Internal Medicine, they have specific expertise in Ehrlichiosis, Human Monocytic Ehrlichiosis, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Wenqing Zhang participate in research or clinical trials?

Yes. Dr. Wenqing Zhang has published 11 articles and abstracts on conditions like Ehrlichiosis. You can view a list of Dr. Wenqing Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Wenqing Zhang accept my insurance?

Dr. Wenqing Zhang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 352-746-0707 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zhang's expertise for a condition
ConditionClose
      View All 17 Advanced Conditions
      View All 98 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile